• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高免疫抑制性 HLA-DR 调节性 T 细胞与宫颈鳞状细胞癌的不良结局相关。

Highly immunosuppressive HLADR regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma.

机构信息

Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Int J Cancer. 2020 Apr 1;146(7):1993-2006. doi: 10.1002/ijc.32782. Epub 2019 Nov 29.

DOI:10.1002/ijc.32782
PMID:31709528
Abstract

Regulatory T cells (Tregs) are crucial for the maintenance of peripheral tolerance, but they also limit beneficial responses through cancer-induced immunoediting. The roles of Treg subsets in cervical squamous cell carcinoma (CSCC) are currently unknown. Here, we aimed to perform an extensive study with an increased resolution of the Treg compartment in the peripheral blood and tumor tissues of CSCC patients. We first identified that an HLADR Treg population in the peripheral blood was significantly increased in CSCC patients compared to precancer patients and healthy donors. We found that HLADR Tregs express high levels of a panel of inhibition and activation markers and the TCR-responsive transcription factors BATF and IRF4. However, this Treg subset showed reduced calcium influx after TCR crosslinking. In addition, HLADR Tregs are highly proliferative and vulnerable to apoptosis. Further studies demonstrated that the HLADR Tregs display high levels of suppressive activity. Quantitative multiplexed immunohistochemistry revealed that an increase in the number of tumor-infiltrating HLADR Tregs is associated with unfavorable classical risk parameters of advanced disease stage and stromal invasion. Context-based quantification revealed that a high frequency of stromal HLADR Tregs in patients is significantly associated with worse progression-free survival. In the current study, we characterized a population of highly activated and immunosuppressive HLADR Tregs in CSCC patients. An increased HLADR Treg frequency may be a potential biomarker to stratify CSCC patients and evaluate therapeutic efficacies in personalized immuno-oncology studies.

摘要

调节性 T 细胞(Tregs)对于维持外周耐受至关重要,但它们也通过癌症诱导的免疫编辑限制了有益的反应。Treg 亚群在宫颈鳞状细胞癌(CSCC)中的作用目前尚不清楚。在这里,我们旨在通过增加 CSCC 患者外周血和肿瘤组织中 Treg 区室的分辨率来进行广泛的研究。我们首先确定,与癌前患者和健康供体相比,CSCC 患者外周血中的 HLADR Treg 群体显著增加。我们发现 HLADR Tregs 表达高水平的一组抑制和激活标志物以及 TCR 反应性转录因子 BATF 和 IRF4。然而,这种 Treg 亚群在 TCR 交联后显示出钙内流减少。此外,HLADR Tregs 具有高增殖性和易凋亡性。进一步的研究表明,HLADR Tregs 具有高水平的抑制活性。定量多重免疫组化显示,肿瘤浸润性 HLADR Tregs 数量的增加与晚期疾病阶段和基质浸润的不利经典风险参数相关。基于背景的定量显示,患者中基质 HLADR Tregs 的高频率与无进展生存期明显相关。在本研究中,我们描述了 CSCC 患者中一群高度活化和免疫抑制的 HLADR Tregs。增加的 HLADR Treg 频率可能是分层 CSCC 患者和评估个性化免疫肿瘤学研究中治疗效果的潜在生物标志物。

相似文献

1
Highly immunosuppressive HLADR regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma.高免疫抑制性 HLA-DR 调节性 T 细胞与宫颈鳞状细胞癌的不良结局相关。
Int J Cancer. 2020 Apr 1;146(7):1993-2006. doi: 10.1002/ijc.32782. Epub 2019 Nov 29.
2
OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.皮肤鳞状细胞癌中的OX40+调节性T细胞抑制效应T细胞反应并与转移潜能相关。
Clin Cancer Res. 2016 Aug 15;22(16):4236-48. doi: 10.1158/1078-0432.CCR-15-2614. Epub 2016 Mar 31.
3
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.具有高度免疫抑制特性的调节性T细胞在乳腺肿瘤微环境中的优先积累。
Oncotarget. 2017 May 16;8(20):33159-33171. doi: 10.18632/oncotarget.16565.
4
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.肿瘤浸润调节性 T 细胞、髓系来源抑制细胞和吲哚胺 2,3-双加氧酶表达与乳腺癌新辅助化疗结局的关系。
Cancer Biol Ther. 2018 Aug 3;19(8):695-705. doi: 10.1080/15384047.2018.1450116. Epub 2018 May 8.
5
Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.调节性 T 淋巴细胞浸润转移性乳腺癌-独立的预后因素,其随着肿瘤进展而变化。
Breast Cancer Res. 2021 Feb 18;23(1):27. doi: 10.1186/s13058-021-01403-0.
6
Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.在大型早期宫颈癌中,功能性肿瘤浸润性 TH1 和 TH2 效应物被调节性 T 细胞抑制。
Int J Gynecol Cancer. 2012 Sep;22(7):1130-7. doi: 10.1097/IGC.0b013e318262aa53.
7
Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.宫颈癌的淋巴结转移发生在盆腔淋巴引流区域明确界定的免疫抑制区域。
Oncotarget. 2015 Oct 20;6(32):32484-93. doi: 10.18632/oncotarget.5398.
8
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
9
Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.调节性 T 细胞耗竭增强了肝癌患者体内由肿瘤抗原 NY-ESO-1b 引发的肿瘤特异性 CD8 T 细胞反应,在体外。
Int J Oncol. 2010 Apr;36(4):841-8. doi: 10.3892/ijo_00000561.
10
Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.肿瘤微环境决定调节性 T 细胞表型:上调的免疫检查点增强抑制功能。
J Immunother Cancer. 2019 Dec 4;7(1):339. doi: 10.1186/s40425-019-0785-8.

引用本文的文献

1
T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.宫颈癌肿瘤微环境中的T细胞亚群:进展与治疗机遇
Front Immunol. 2025 Jun 5;16:1612032. doi: 10.3389/fimmu.2025.1612032. eCollection 2025.
2
PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression.过氧化物酶体增殖物激活受体δ通过限制II类主要组织相容性复合体反式激活因子的表达来抑制肿瘤内调节性T细胞的抑制功能。
bioRxiv. 2024 Dec 20:2024.12.16.628819. doi: 10.1101/2024.12.16.628819.
3
Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients.
程序性死亡配体-1作为胰腺癌患者新的预后生物标志物的研究
ACS Pharmacol Transl Sci. 2024 Oct 7;7(11):3585-3591. doi: 10.1021/acsptsci.4c00490. eCollection 2024 Nov 8.
4
The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis.Th17/Treg细胞在宫颈癌中的预后价值:一项系统评价与荟萃分析。
Front Oncol. 2024 Sep 11;14:1442103. doi: 10.3389/fonc.2024.1442103. eCollection 2024.
5
HLA-DR regulatory T cells and IL-10 are associated with success or failure of desensitization outcomes.HLA-DR调节性T细胞和白细胞介素-10与脱敏治疗结果的成败相关。
Allergy. 2025 Mar;80(3):762-774. doi: 10.1111/all.16311. Epub 2024 Sep 18.
6
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function.超越 FOXP3 定义人类调节性 T 细胞:需要将表型与功能相结合。
Cells. 2024 May 30;13(11):941. doi: 10.3390/cells13110941.
7
The immune microenvironment of cancer of the uterine cervix.宫颈癌的免疫微环境。
Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.
8
A disrupted FOXP3 transcriptional signature underpins systemic regulatory T cell insufficiency in early pregnancy failure.FOXP3转录特征的破坏是早期妊娠失败中系统性调节性T细胞功能不全的基础。
iScience. 2024 Jan 23;27(2):108994. doi: 10.1016/j.isci.2024.108994. eCollection 2024 Feb 16.
9
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.超越 FOXP3:解析人类调节性 T 细胞异质性的 20 年历程。
Front Immunol. 2024 Jan 12;14:1321228. doi: 10.3389/fimmu.2023.1321228. eCollection 2023.
10
CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor.CNKSR2表达与宫颈癌中的免疫浸润相关,是一个有利的预后因素。
J Cancer. 2024 Jan 1;15(2):444-455. doi: 10.7150/jca.87622. eCollection 2024.